Neuland Laboratories EV / EBITDA
Cos'è EV / EBITDA di Neuland Laboratories?
EV / EBITDA di Neuland Laboratories Limited è 21.69
Qual è la definizione di EV / EBITDA?
EV / EBITDA è il valore aziendale diviso per guadagni prima di interessi, tasse, deprezzamento e ammortamento. È una misura di quanto sia costosa una azione ed è più frequentemente valida per i confronti tra le aziende rispetto al rapporto prezzo / guadagno. Misura il prezzo (sotto forma di valore d'impresa) che un investitore paga a vantaggio del flusso di cassa della società (sotto forma di EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA di aziende nel Health Care settore su BSE rispetto a Neuland Laboratories
Cosa fa Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Aziende con ev / ebitda simili a Neuland Laboratories
- Life Storage Inc ha EV / EBITDA di 21.65
- Invitation Homes Inc ha EV / EBITDA di 21.67
- Extra Space Storage ha EV / EBITDA di 21.67
- Paramount Communications ha EV / EBITDA di 21.68
- Surana Solar ha EV / EBITDA di 21.68
- Tungsten plc ha EV / EBITDA di 21.69
- Neuland Laboratories ha EV / EBITDA di 21.69
- Chesapeake ha EV / EBITDA di 21.69
- Edenred SA ha EV / EBITDA di 21.70
- Henderson Land Development ha EV / EBITDA di 21.70
- Dow Inc ha EV / EBITDA di 21.71
- Yum China Inc ha EV / EBITDA di 21.71
- Hindustan Composites ha EV / EBITDA di 21.71